The McDonald criteria revisions provide a unified approach for diagnosing MS from pediatric to late-life presentations, said ...

Researchers in Japan discovered that Parkinson’s patients diagnosed in their 80s are far more likely to show signs of amyloid ...

In addition, the team discovered that plasma total tau—not just the modified pTau217 form—was elevated in newborns. This is ...

Alzheimer’s disease is characterized by certain key changes in the brain. Among them are the development of two kinds of ...

The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.

Alterity presents positive phase II data for ATH434 at 2025 International Congress of Parkinson’s Disease and Movement Disorders. Alterity presents positive phase II data for ATH434 at 2025 ...

New Blood-Based Assay Delivers Unparalleled Sensitivity and Specificity to enable the next generation of assay development.

A landmark placebo-controlled trial shows shunting improves walking and reduces falls in idiopathic normal-pressure ...

Burlington-based Labcorp has launched the first blood-based test cleared by the U.S. Food and Drug Administration (FDA) for aiding in the diagnosis of Alzheimer's disease.

Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension –– New analysis increases overall confidence in the ...

The 2024 McDonald criteria, published just before the 2025 ECTRIMS Congress, substantially expand criteria for a probable ...